Acceptability and feasibility of enhanced cognitive behavioral therapy (eCBT) for children and adolescents with obsessive-compulsive disorder.

Adolescents Children Cognitive behavioral therapy (CBT) Enhanced cognitive behavioral therapy (eCBT) Obsessive–compulsive disorder (OCD)

Journal

Child and adolescent psychiatry and mental health
ISSN: 1753-2000
Titre abrégé: Child Adolesc Psychiatry Ment Health
Pays: England
ID NLM: 101297974

Informations de publication

Date de publication:
04 Sep 2021
Historique:
received: 23 11 2020
accepted: 27 08 2021
entrez: 5 9 2021
pubmed: 6 9 2021
medline: 6 9 2021
Statut: epublish

Résumé

Obsessive-compulsive disorder (OCD) is a disabling mental health disorder affecting 1-3% of children and adolescents. Cognitive behavioral therapy (CBT) is recommended as the first-line treatment, but is limited by accessibility, availability, and, in some cases, response to treatment. Enhancement with Internet technologies may mitigate these challenges. We developed an enhanced CBT (eCBT) treatment package for children and adolescents with OCD to improve treatment effect as well as user-friendliness. This study aims to explore the feasibility, acceptability, and preliminary effectiveness of the eCBT intervention. The eCBT protocol consists of 10 face-to-face and 12 webcam sessions delivered in 14 weeks. CBT is enhanced by a smartphone application (app) for children and parents to support and monitor treatment, psychoeducative videos, and therapist-guided webcam exposure exercises conducted at home. Assessments were performed at baseline, post-treatment, and at 3- and 6-month follow-up. Primary measures of outcomes were the the Client Satisfaction Questionnaire-8 (CSQ-8) (acceptability), treatment drop-out (feasibility) and the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) (preliminary effectiveness). This paper describes 25 patients with OCD (aged 8-17 years) treated with eCBT. Results indicated that children and parents were satisfied with eCBT, with CSQ-8 mean scores of 27.58 (SD 0.67) and 29.5 (SD 3.74), respectively (range 8-32). No patients dropped out from treatment. We found a mean of 63.8% symptom reduction on the CY-BOCS from baseline to post-treatment. CY-BOCS scores further decreased during 3-month and 6-month follow-up. In this explorative study, eCBT for pediatric OCD was a feasible, acceptable intervention demonstrating positive treatment outcomes.

Identifiants

pubmed: 34481523
doi: 10.1186/s13034-021-00400-7
pii: 10.1186/s13034-021-00400-7
pmc: PMC8418719
doi:

Types de publication

Journal Article

Langues

eng

Pagination

47

Informations de copyright

© 2021. The Author(s).

Références

Eur Child Adolesc Psychiatry. 2015 Sep;24(9):1061-74
pubmed: 25527002
BJPsych Open. 2018 Apr 18;4(3):106-112
pubmed: 29971153
Psychiatry Res. 2004 Nov 30;129(1):91-8
pubmed: 15572188
Depress Anxiety. 2010 May;27(5):470-5
pubmed: 20455248
Psychiatry (Edgmont). 2007 Jul;4(7):28-37
pubmed: 20526405
PLoS One. 2014 Jun 20;9(6):e100773
pubmed: 24949622
J Am Acad Child Adolesc Psychiatry. 2010 Jul;49(7):708-17
pubmed: 20610140
Acta Psychiatr Scand. 2002 Aug;106(2):143-9
pubmed: 12121213
Int J Methods Psychiatr Res. 2012 Sep;21(3):169-84
pubmed: 22865617
JAMA. 2011 Sep 21;306(11):1224-32
pubmed: 21934055
Med Sci Monit. 2016 May 16;22:1646-53
pubmed: 27182928
J Psychiatr Res. 2013 Jan;47(1):33-41
pubmed: 22999486
Psychiatry Res. 2011 Oct 30;189(3):407-12
pubmed: 21684018
Eval Program Plann. 1983;6(3-4):395-400
pubmed: 10267266
J Child Psychol Psychiatry. 1997 Nov;38(8):1051-62
pubmed: 9413802
J Am Acad Child Adolesc Psychiatry. 2000 Jan;39(1):49-58
pubmed: 10638067
Syst Rev. 2019 Nov 20;8(1):284
pubmed: 31747935
J Anxiety Disord. 2016 Aug;42:85-94
pubmed: 27395805
Eval Program Plann. 1982;5(3):233-7
pubmed: 10259963
J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1149-61
pubmed: 22024003
Acta Psychiatr Scand. 2004 Jul;110(1):4-13
pubmed: 15180774
J Am Acad Child Adolesc Psychiatry. 2017 Jan;56(1):10-19.e2
pubmed: 27993223
Br J Psychiatry. 2001 Oct;179:324-9
pubmed: 11581112
J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S61-9
pubmed: 12880501
Behav Res Ther. 2015 Jan;64:15-23
pubmed: 25463245
Int J Psychiatry Clin Pract. 2013 Aug;17(3):179-87
pubmed: 23428237
Psychiatr Clin North Am. 1992 Dec;15(4):861-9
pubmed: 1461801

Auteurs

Lucía Babiano-Espinosa (L)

Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Child and Adolescent Psychiatry, St. Olav's University Hospital, Trondheim, Norway.

Lidewij H Wolters (LH)

Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway.

Bernhard Weidle (B)

Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Child and Adolescent Psychiatry, St. Olav's University Hospital, Trondheim, Norway.

Scott N Compton (SN)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.

Stian Lydersen (S)

Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Child and Adolescent Psychiatry, St. Olav's University Hospital, Trondheim, Norway.

Norbert Skokauskas (N)

Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway. norbert.skokauskas@ntnu.no.
Department of Child and Adolescent Psychiatry, St. Olav's University Hospital, Trondheim, Norway. norbert.skokauskas@ntnu.no.

Classifications MeSH